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Normal human epidermis, long since dismissed as merely a protective covering
for the body, is now recognized as a complex immunological unit. This concept is
based on the demonstration that Langerhans cells (LCs)t are potent APCs fora va-
riety ofT cell (TC) responses and that keratinocytes (KC), at least upon stimula-
tion, can secrete a plethora ofimmunomodulating cytokines (reviewed in reference
1). Finally, it has been known for almost 40 years that the normal human epidermis
harbors lymphocytic-appearing cells (2), yet surprisingly this cell population has re-
ceived little attentionsincethen. Therelatively recent discoveryofaTCRy/S-bearing
lymphocyte population (DETC, dendritic epidermal Tcell) inthe mouseepidermis
(reviewed in reference 1) has rekindled interest in the possibility not only that the
epidermis mayfunction as an extrathymic microenvironment for thedifferentiation
and/or "education" ofTCs but also that a resident TC population may exist in the
human epidermis, particularly an equivalent to the murine DETC. While some in-
vestigators never, or only rarely, observed epidermal TCs in normal skin (3, 4), we
and others havefoundthem toberoutinely detectable in nonlesional, clinicallynormal
skin (5-9). Inthisstudywehave sought to (a)more fully describe the heterogeneous
phenotypeofepidermalTCs, particularlywith regard to TCR-a/o-- and --y/b-bearing
subpopulations, (b) examine ultrastructural features ofimmunolabeled epidermal
TCs, (c) quantitate this population in various body regions, (d) examine their in
This work was supportedin part by a NATO fellowship (C. A. Foster) from the National Science Foun-
dation (USA), grant 7298-MED from the Fonds zurForderungderwissenschaftlichen Forschung(Vienna,
Austria), and a grant from the Burgermeisterfonds der Stadt Wien. H. Yokozeki's current address is
Kitasato University School of Medicine, 1 Asamizodai, Sagamihara-Shi, Kanagawa-Ken, Japan. F.
Koning's present address is Academisch Ziekenhuis Leiden, Immunohematology andBloodBank, Rijns-
burgerweg 10, 2333 AA Leiden, The Netherlands.
Addresscorrespondence to Carolyn A. Foster, Sandoz Research Institute, BrunnerStrasse59,A-1235,
Vienna, Austria.
1 Abbreviations used in thispaper . ABC, streptavidin-biotin-complex; CD, cluster ofdifferentiation; DAB,
3;3'-diaminobenzidine; DETC,dendritic epidermalTcell; EC, epidermalcell(s);GAM, goat anti-mouse;
IIF, indirect immunofiuorescence;IIP, indirect immunoperoxidase; KC, keratinocyte(s);LC(s), Langer-
hans cell(s); NGS, normal goat serum; RT,room temperature; SALT,skin-associated lymphoid tissues;
TC(s), T cell/lymphocyte(s); WM, washing medium.
J. Exp. MED. C The Rockefeller University Press - 0022-1007/90/04/0997/17 $2.00
￿
997
Volume 171 April 1990 997-1013998
￿
T CELLS IN THE NORMAL HUMAN EPIDERMIS
situ relationship to LCs (e) investigate the growth potential ofepidermal TCs in vitro,
and ()) characterize the phenotype and CD3-associated TCR complex of cultured
epidermal TCs by FRCS analysis and immunoprecipitation.
Materials and Methods
Specimen Collection
Full- or split-thickness skin biopsies from clinically normal-appearing areas were obtained
during elective surgery under local anesthesia and from autopsy specimens using a derma-
tome (Davol/Simon, Cranston, RI). Skin from 50 individuals was examined, and for some
aspects of this study, represented six different body regions (i.e., ventral thigh and upper arm,
chest, buttock, back, sole [posterior to "ball of foot"]).
Preparation of Tissue
Frozen Sections.
￿
Using standard techniques, full-thickness skin biopsies were snap frozen
in a liquid nitrogen bath and embedded in OCT compound (Miles Laboratories, Naperville,
IL). 5-pm-thick sections were acetone-fixed for 10 min at 4°C .
Epidermal Sheets.
￿
Keratomed, split-thickness skin (sole or thigh) was rinsed in washing
medium (WM: = RPMI 1640 [Gibco Ltd., Paisley, Scotland] supplemented with 10% FCS
(Flow Laboratories, Ltd., Ayrshire, Scotland], 2 mM glutamine [Flow], 25 mM Hepes buffer
[Flow], 50 pg/ml gentamicin [Flow], and an antibiotic-antimycotic solution [Gibco] consisting
of 100 pg/ml penicillin, 100 p.g/ml streptomycine, 0.25 Fig/ml Fungizone), then cut into 3-4-
cm2 pieces. Epidermal sheets were prepared by using either the ammonium thiocyanate sepa-
ration technique (10) or 3 U/ml dispase (Boehringer-Mannheim, Mannheim, FRG), as pre-
viously reported (11).
Epidermal CellSuspensions.
￿
Under sterile conditions, keratomed skin was incubated for 1 h
at room temperature (RT) in WM additionally supplemented with a 10 x concentration of
the antibiotic/antimycotic solution, followed by a wash in PBS without calcium and mag-
nesium (Dulbeccds PBS), pH 7 .6. Epidermal sheets were prepared using either the dispase
method (11) or PBS with 0.25% trypsin (Gibco Ltd.) for 1 h at 37°C, then these were placed
in WM containing 0.025% deoxyribonuclease I (Sigma Chemical Co., St. Louis, MO). After
20-30 min at RT the sheets were vigorously stirred, and the resulting cell suspension was
poured through a sterile nylon gauze sieve to remove large clumps ofcells. Viability was rou-
tinely 70-90%, as determined by trypan blue exclusion.
Enrichment of Epidermal T Cells.
￿
Preliminary observations showed that unfractionated
epidermal cell (EC) suspensions contain only minute numbers ofTCs. Therefore, to increase
the percentage ofTCs within the EC suspension, and thus improve the chances ofstimulating
their proliferation in vitro, we used a technique that results in the elimination of most KC
and also leads to a substantial enrichment of LCs (Yokozeki et al., manuscript in prepara-
tion). In brief, EC suspensions were incubated for 1 h at 37°C in tissue culture flasks that
had been coated with Vitrogen 100 (Collagen Corp., Palo Alto, CA). Nonadherent cells were
resuspended in ice-cold PBS with simultaneous vortexing. This treatment selectively killed
the majority of KC, which were subsequently removed by density gradient centrifugation.
The interface cells (enriched for TCs) were collected and prepared for the appropriate ex-
periments, as described below.
Immunolabeling Procedures
Staining was performed by using either indirect immunofluorescence (IIF), indirect im-
munoperoxidase (IIP), or a peroxidase-conjugated ABC (streptavidin-biotin-complex) tech-
nique. In each method, irrelevant mAbs of the appropriate Ig isotype were used as negative
controls. To assay for endogenous peroxidase activity, both primary and secondary antibodies
were omitted from the procedure.
Frozen Sections.
￿
Regardless of the staining method (IIF, IIP, or ABC), sections were pre-
blocked in 10% normal goat serum (NGS) for 30 min at RT then incubated in the primary
mAb (Table I) overnight at 4°C or 6 h RT, followed by a PBS wash and another 30 min
incubation in 10% NGS. For 1117, the sections then were incubated in a 1 :30 dilution of eitherFOSTER ET AL.
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TABLE I
mAbs for Immunolabeling Epidermal Sheets,
Cell Suspensions and Frozen Sections
' Mouse anti-human mAb, unless designated otherwise .
x BD, Becton Dickinson ; B, Behring; C, Coulter; D, Dako; MB, gift from M.
Brenner (Boston, MA); O, Ortho Diagnostics; TS, T Cell Sciences.
rhodamine-conjugated goat anti-mouse (GAM) IgG (Atlantic Antibodies, Scarborough, ME)
or FITC-conjugated F(ab')2 GAM IgG (Tago Inc., Burlingame, CA) for 1-2 h at RT, washed
in PBS, and coverslipped in mounting fluid (Difco Laboratories, Detroit, MI).
In the ABC method, sections were incubated in a 1 :200 dilution of biotinylated sheep
anti-mouse IgG (Amersham International, Amersham, U. K.) for 1-2 h at RT, washed in
PBS, then treated with the peroxidase-ABC solution (Dakopatts a/s, Glostrup, Denmark) for
1 h at RT, according to manufacturer's instructions. Finally, sections were incubated in 3-
amino-9-ethylcarbazole (Sigma) for 5-10 min, then washed, counterstained with hematox-
ylin, and coverslipped in Aquamount (BDH Ltd ., Poole, UK).
For IIP staining, sections were incubated in a 1 :100 dilution ofperoxidase-conjugated sheep
anti-mouse IgG (Amersham) for 1-2 h at RT, washed in PBS, and subjected to the 3',3'-
diaminobenzidine (DAB) reaction.
Epidermal Sheets.
￿
Sheets were fixed in either acetone for 3 min at RT or in Nakane's fixa-
tive (12) for 1 h at RT. The sheets were stained by either the IIF or IIP technique (as described
above for frozen sections), then coverslipped (basal surface facing up) in mounting fluid (Difco).
Cluster
of
differentiation
mAb
used* Sourcet
IgG
subclass
Antigen specificity/cellular
expression
CDIa OKT6 O IgGI T6/cortical thymocytes ; LCs
CD2 Leu 56 BD IgG2a TI I/sheep erythrocyte
rosette receptor; pan TC
CD3 Leu 4 BD IgGI T3 complex antigen
CD4 Leu 3a BD IgGI T4/helper-inducer TC
CD5 Leu 1 BD IgG2a pan TC
CD7 Leu 9 BD IgG2a pan TC
CD8 Dako-T8 D IgGI T8/supprcssor-cytotoxic
Leu 2a BD IgGI TC
CD14 Leu M3 BD IgG2b Monocytes/macrophages
CD16 Leu 1la BD IgGI IgG Fc receptor on NK
cells and neutrophils
CD19 Leu 12 BD IgGI B cells (134)
CD20 Leu 16 BD IgGI B cells (131)
CD25 Dako IL2R D IgGI IL-2 receptor (Tae antigen)
a-IL2R BD IgGI on activated TCs
CD29 4134 C IgGI Subset of B and TCs
CD45 HLe-1 BD IgGI Pan leukocyte
CD45 Dako-LC D IgGI Pan-leukocyte, except
for LCs
CD45RA 2H4 C IgGI Unsensitized TCs
CD45RO UCHL1 D IgG2a Memory TCs
- VLA-1 TS IgGI TC late activation antigen
- HLA-DR BD IgG2a Class II MHC antigen
- WT31 BD IgGI TCR-a//3
BMA031 B IgG2b TCR-cYf
0171 TS IgGI TCR /3 chain, framework
- 6TCSI TS IgGI TCR V61
- TCR61 TS/MB IgGI TCR 6 chain, framework1000
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Double Labeling of Frozen Sections andEpidermal Sheets.
￿
Double labeling of either sections
or epidermal sheets wasperformedusingan IIFtechnique(asdescribedabove, with therhoda-
mine conjugate) for visualization of the first mAB, followed by a 1 h incubation at RT in
l0olo normal mouse serum and 10°Jo NGS. Specimens then were stained with a FITC-
conjugated mAb, usually at high concentrations (1 :10), for a 2-4 h at RT, then washed.
Cell Suspensions.
￿
Cultured TCs, and EC suspensions enriched forTCs, were immunola-
beled with abattery of mAbs (Table I) by astandard IIFtechniqueusingFITC-conjugated
F(ab')2 GAM IgG (Tago) as the second antibody for 15 min at 4°C. For negative controls,
the primary mAb was substituted by either PBS or irrelevant antibodies of the appropriate
subclass. Cells were either examined with a fluorescence microscope or analyzed on aFACS
Analyzer (BD, Sunnyvale, CA), using 10,000 cells/sample. Nonviable cells were gated out
by propidium iodide staining.
Transmission Electron Microscopy.
￿
Epidermal sheets or thin slices of skin (80-100/Am thick)
were immersed in Nakane's fixative (12) for 1 h at RT, washed in PBS/7.5% sucrose, then
preblocked in 10% normal horse serum for 1 h at RT. The specimens were incubated in the
primary mAb (diluted in PBS/sucrose) for 6-12 h at 4oC. After washing in PBS/sucrose, the
tissue was incubated in a 1:50dilution of biotinylated horseanti-mouse IgG(VectorLabora-
tories Inc., Burlingame, CA) for 4-6 h at 4oC, rinsed, and incubated in a 1:100 dilution
of a peroxidase-conjugated ABC solution (Vector) for 4-6 h at 4oC. The specimens were
immersed in half-strength Karnovsky's fixative (13) for30 minat 4oC, washed in 0.2 M caco-
dylate buffer, then incubated in 0.02% DAB solution for 30 min at RT. The tissue was post-
fixed in 2% OsO4-potassium ferrocyanide for 1 h at 4oC and processed for Epon-
embedment. Thin sections were lightly stained, as previously described (14), and examined
with aJEOL 1200EX electron microscope.
Quantitation Method
To use a large panel of mAbs on each individual skin specimen and to evaluate staining
patterns in both theepidermis anddermis, allof the quantitative data presented in this study
were derived from cryostat sections and compared in five body regions (Table II), i.e., chest
[5]; buttock [5]; sole [8]; and limbs, e. g., thigh [2] + upper arm [3]. The mean number
of peroxidase-labeled cells t SD was calculated in three to six sections per specimen, using
a 40 x objective, and normalized forthe number of cells per linear centimeter ofepidermis.
Only clearly stained cell bodies were counted.
Statistical Analysis
Themean number ofTCs/linear cm ofepidermisdoes notnecessarily conform to the defi-
nition of anormally-distributed population. Therefore anon-parametric analysis ofvariance,
usingthe Kruskal-Wallis test (15), wasemployed to determinewhethertherewere differences
between the number of epidermal CD2'/CD3' cells within the four treatment groups (thor-
ax, limbs, buttock, sole). Observed differences were analyzed usingtheMann-Whitney U-test
(16) and were considered significant if p 4 0.05.
Culture of Epidermal T Cells
EC suspensions enriched forTCs(aswell as LCs) were incubatedin complete culture media
(WM with 1% nonessential aminoacids [Flow] and 100 mM sodium pyruvate [Flow]) sup-
plemented with 5 Wg/ml Con A (Pharmacia Fine Chemicals, Uppsala, Sweden), 40 U/ml
rIL-1 (Genzyme Corp., Boston, MA), 100 U/ml rIL-2 (Amersham), and 10°Jo A431 cell cul-
ture supernatant (concentrated 10 x from a 3-d subconfluent population, using an Amicon
filter [Amicon Ltd., Stonehouse, UK]). The cell suspensions were seeded at a high density
in appropriate tissue culture plates/flasks and incubated at 37'C in 5% C02.
Immunoprecipitation and SDS-PAGE Analysis
Cellscultured from TC-enriched EC suspensions were investigated fortheir TCRconfigu-
ration using an immunoprecipitation technique with mouse anti-human CD36 and rabbit
anti-human TCRct, anti-human TCR/3, anti-human TCR,y antibodies, as described by
Koning and colleagues (17, 18).H
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Results
A heterogeneous population of hematopoietic cells (CD45') was observed in the
epidermis of clinically normal-appearing skin from almost every specimen exam-
ined . Double immunolabeling with anti-CD45 and either anti-CD1a, anti-CD2, or
anti-CD3 mAbs (see Table I) demonstrated two discrete subpopulations ofCD45'
cells (Fig . 1) . The majority were CDla'/HLA-DR', highly dendritic, suprabasally
located cells, which by definition corresponded to LCs. CDla' cells were occasion-
ally UCHL1', which to our knowledge is a new but not surprising observation, and
frequently CD4' . However, LCs did not express CD2, CD3, CD5, CD7, or CD8
antigens (we therefore can not substantiate the previously reported occurrence [19]
of C133-associatedTCR moieties on CDla' epidermal cells) . Furthermore, LCs also
were unreactive with the mAb Dako LC (20) (product name refers to "leukocyte
common"antigen andnot to Langerhans cell), whichsupposedly belongsto theCD45
cluster ; thus, in our opinion the Dako-LC reagent should not be considered as a
classical anti-CD45 mAb.
The other epidermal CD45' population (Fig . 1 b) consisted of CDla-/CD2'/
CD3'/Dako LC' cells that were smaller than LCs, truncate or slightly dendritic,
and located in either the basal or suprabasal layer. Neither CD2'/CD3 - norCD2-/
CD3' cells were encountered within the epidermis . Monocytes/macrophages, nat-
ural killer cells, and B cells also were not observed within the epidermal compart-
ment, as judged by lack of reactivity with anti-CD14, -CD16 and -CD19/20 reagents,
respectively. Therefore, throughout this study we will refer to the
CD45'/CDla/CD2'/CD3' population within the epidermis asT lymphocytes, in
accordance with our present state ofknowledge regarding TC differentiation an-
tigens ; the mean number ofTCs exhibiting this phenotype will be used as a refer-
ence point in comparing their density with that of other immunolabeled cells .
Phenotype, Distribution, Regional Variability, andDensity ofEpidermal Ms.
￿
Epidermal
TCs (i.e., CD2'/CD3') were almost exclusively CD5' (Table 11) . They were distin-
guishable from LCs not only phenotypically but also morphologically, since TCs
had amore spherical nuclearprofile with a higher nuclear-to-cytoplasmic ratio, lacked
Birbeck granules, and exhibited a denser cytoplasm due to the abundance of free
ribosomes and nonaggregated, intermediate-size filaments (Fig . 2) . Also, TCs usu-
FIGURE 1 .
￿
Double immunostain of rhodamine-labeled CD45* (a)and FITC-labeled CD3' (b)
epidermal cells in a frozen section of back skin . A CD45'/CD3' TC is depicted within the basal
KC layer (arrowhead), while LCs represent the majority of CD45' cells. In every double-labeling
experiment, CD3' TCs coexpressed CD2 antigens (photograph not included). D, dermis . x 120 .FOSTER ET AL .
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FIGURE 2 .
￿
Three electron micrographs of an epidermal sheet from the thigh, immunolabeled
with anti-Leu 1 . (a) Low power view ofa peroxidase-labeled CD5' TC (arrows) within the basal
KC layer; DEJ, dermal-epidermal junction. x7,000 . (b) Portion ofan adjacent LC showing Bir-
beck granules, and as expected, noCD5 reactivity ; x45,000 . (c) Higher magnification ofanother
CD5' TC-exhibiting peroxidase reaction product along the plasma membrane and a typical cy-
toplasmic granule (arrow) . x47,300 .
ally contained a few small cytoplasmic granules that were round to ovoid with a
central, osmiophilic core (Fig. 2 c) ; organelles resembling melanosomes or Merkel
cell granules were never observed .
A large percentage of epidermal TCs reacted with antiTCR-a/(3 mAbs (Tables
1, I1) . In contrast, TCR-,y/&-bearing cellswere seen only occasionally within thebasal
KC layer and follicular epithelium, as identified by pan S chain and antiVbl re-
agents (Table 1), andwere most prevalent in thedermis . In contrast to theperipheral
blood where almost all TCs express CD7, only 15-30% of the epidermal1004
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CD2'/CD3' population were CD7' . As opposed to the situation in peripheral blood
(21), CD8' cells represented the dominant subset within the epidermis (N3 :2 ratio
of CD8' to CD4' TCs), and this pattern was most pronounced in the sole . Al-
though some epidermal TCs were in the activated state, as determined by the ex-
pression ofHLA-DR, CD25, or late activation antigen VLA-1, the majority lacked
these markers (Table 11, Fig . 3, a and b) and were regarded as being in the "resting"
state . The sole had fewer activated cells (6% of CD2'/CD3` population) than the
other body regions (32% of TCs), and in contrast to those in nonvolar sites that
were primarily CD25'/VLA-1 - , activated TCs in the plantar epidermis were
CD25-/VLA-1' .
To ascertain whether the epidermal TC population consists primarily of "virgin"
unsensitized cells or sensitized ones with "memory,"we immunolabeled skin sections
with the mAbs 2H4 (CD45RA) andUCHLI (CD45RO), which purportedly iden-
tify these reciprocal subsets, respectively (22-25) . Most epidermalTCs were primed
memory cells (73% ofCD2'/CD3'), based on 2H4-/UCHLI' reactivity, while only
N20% were 2H4' (Table 11) . This trend was observed more consistently in the sole
than in the trunk and extremities . Efforts to stain with anti-4B4mAb(CD29), which
is specific for the (3, chain of the integrin family (reviewed in reference 26) and is
reported to identify memoryTCs (25), yielded uninterpretable results since thebasal
KC layer was routinely 4B4', an observation also made by others (7) .
Epidermal TCs were randomly distributed between basal/suprabasal KC (Fig .
2) in body regions where the dermal papillae are typically shallow (Fig . 1), with
no apparent preference for a particular site within this horizontal plane . However,
FIGURE 3 .
￿
Two different double-staining experiments using sole skin . The left side (a and b)
shows one frozen section that wasimmunolabeled with anti-Leu 4 (a, rhodamine stain) andFITC-
conjugated anti-HLA-DR (b) . a and b, respectively, show CD3'/HLA-DR- epidermal and
subepidermal TCs (arrowheads) in the same section . Most ofthe HLA-DR reactivity is restricted
to the dermal macrophages, endothelium (arrow), and intensely staining acrosyringium (A) ; E,
epidermis ; D, dermis . x190 . The right panels (c and d) depict another section of skin that was
labeled with FITC-conjugated OKT6 (c) and anti-Leu 4 (d, rhodamine stain), illustrating the
close association between a CDla'/CD3- LC (c) within the acrosyringium and numerous
epidermal CD3' TCs (d) . Dotted line denotes the dermal-epidermal junction, thus showing the
position of TCs in the dermis (D). x 180 .FOSTER ET AL .
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where thedermal-epidermal contour is more exaggerated (e.g., sole), TCsweremore
common alongthe rete ridges than above the dermal papillae and usuallyappeared
to be present in a random, nonclustered pattern, which was most evident by en face
examination of epidermal sheets after immunolabeling with a panTC marker (Fig .
4 a) . Epidermal TCs not only had a predilection for rete ridges, particularly around
the tip, but also for the outer root sheath of hair follicles and the acrosyringial epi-
theliumof sweatducts (Fig . 4b) . Because of the regular, lattice-like position of sweat
glands within the sole and the propensity that TCs apparently have for this epithe-
lium, one could often see apattern ofTC clusters associated with theacrosyringium
FIGURE 4 .
￿
EpidermalTCs in plantar skin. (a)En face, basal-surface view ofan epidermal sheet
from the sole showingnumerous rhodamine-labeledCD3' cells distributed along the rete ridges.
x 160. (b) Frozen section ofplantar skin with peroxidase-stained CD2' cells (arrowhead) concen-
trated within the acrosyringial epithelium of a sweat gland . E, epidermis ; x190. (c) Low power
micrograph of a thick (>6 pm) frozen section of plantar skin showing epidermal and dermal
clusters of peroxidase-labeled CD8' TCs (arrow) associated with the sweat ducts . Note that rela-
tively few CD8' TCs are present in the reticular dermis (D) . x50.1006
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that corresponded to the location of sweat ducts protruding into the dermis through
alternating rete ridges (Fig. 4 c). Dermal T lymphocytes often were clustered just
beneath the basement membrane in these epidermal TC-rich sites, usually in con-
centric layers two to four cell layers thick. In addition to this focal concentration
at the dermal-epidermal junction and within connective tissue sheaths of adnexal
appendages, dermal TCs frequently were localized around superficial vessels. How-
ever, the concentration of intra- and subepidermal TCs often was strikingly high
in comparison to the TC population within the deeper dermis (Figs. 4, b and c).
There was no statistical difference (p > 0.01) in the density of epidermal TCs be-
tween thigh, upper arm, buttock, and chest. In these regions, the mean number
of CD2'/CD3' TC was eight per linear centimeter of epidermis. However, within
the epidermis of sole skin (Fig. 4) the density of TCs was significantly higher (p <
0.0001), with an average of 40 CD2`/CD3' cells per linear centimeter of epidermis
(Table II). The density of LCs in the sole was 40% less than in the other four areas
examined (Foster, C. A., and B. Volc-Platzer, unpublished data), and because TCs
were five times more abundant in the sole epidermis, the ratio of CD2+/CD3' TC
to LC in plantar skin was 1:1 .7 (i.e., 63 17o of the LC population) as compared with
only 1:20 (i.e., 6% of the CD1a' cells) in other epidermal regions.
In Situ Relationship ofEpidermal TC andLC.
￿
Anti-CDla/anti-CD3 double labeling
revealed that TCs were sometimes in close proximity to LCs in clinically normal-
appearing skin (Fig. 3, c and d). By electron microscopy, it was apparent that this
TC-LC association often involved an intimate glycocalyx-to-glycocalyx contact be-
tween the two cell types (Figs. 5, 6). In some cases this cellular relationship resem-
bled a tight junction, while in other zones of contact the TC and LC membranes
appeared to be fused and were indistinguishable from one another (Fig. 6) .
In VitroActivation and Characterization ofEpidermal TCells.
￿
When TC-enriched EC
suspensions were cultured in 5 ttg/ml Con A, 40 U/ml rIL-1, 100 U/ml rIL-2, and
10% A431 cell culture supernatant, a population of club- or Y-shaped cells began
proliferating after 4-7 d and finally overgrew the other EC . From 12 different indi-
viduals, we established cultures that could be maintained in a growth phase for4-9
wk and found that the proliferating cells were routinely CD45', CD2', CD3',
CDla- (FAGS profiles not shown). While most of these were usually CD5', CD25',
and HLA-DR', anti-CD7 reactivity was highly variable (10-90%). Although a few
cultures consisted of either CD4' TCs or an equal number of CD4 and CD8 single-
positive cells, CD4-/CD8' TCs predominated in the majority of cultures, thus
closely reflecting the in situ observation. In one culture there was evidence for a
substantial CD4-/CD8- subpopulation; however, these double-negative cells ceased
to proliferate before they could be thoroughly phenotyped.
Immunolabeling forTCR proteins demonstrated that most of the cultures reacted
with antiTCR-a//3 mAbs (BMA031 and WT31). To investigate the molecular form
ofTCR-a//3 dimers in epidermal TCs, some cultures were analyzed by immunopre-
cipitation using antiTCRa, antiTCR-/3, antiTCR-y, and anti-CD3S sera. Using
digitonin lysates (maintains CD3TCR bond), the anti-CD3S serum precipitated
the CD3 complex in association with a 90-kD disulfide-linked heterodimer which,
under reducing conditions, dissociated into a 40-45-kD band (Fig. 7 a, lane 5). Es-
sentially identical bands of 40-45 kD were precipitated by antiTCRa and -/3 but
not by anti--y (Fig. 7 a, lanes 2-4) using an NP-40 (dissociates TCR from CD3)FOSTER ET AL.
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FIGURE 5 .
￿
Electron micrograph of an epidermal TC (in thigh skin) that is wrapped around
aCDla' peroxidase-labeled LC process (arrowheads) . Intermediate size filaments are abundant
within the TC cytoplasm . x 16,000.
lysate, indicating that the dimer consisted of disulfide-linked a/(3 chains that ap-
peared identical to those seen in noncutaneous TCs (reviewed in reference 27) . In
two other epidermalTC cultures (FAGS profiles not shown), the cells either were
almost exclusively TCR-7/6' (mAbs 6TCS1 and TCRbl), as well as CD2+/CD3'/
CD4-/CD8' and plastic adherent, or consisted of TCR-a/0' and TCR- ,y/6'
(nonadherent) subpopulations, as demonstrated by immunoprecipitation in Fig. 7
b . Theprotein precipitated with antiserum to TCR-y was -43kD (Fig . 7 b, lane 4) .
Discussion
The present study has shown that in clinically normal-appearing adult human
skin, epidermal TCs represent a minor but routinely identifiable population . The
majority are basally located, CD2'/CD3'/CD5'/CD8', and exhibit the phenotype
of "memory" cells (i .e ., 2H4-/UCHL1') in an unactivated state (i.e ., HLA-DR-/
CD25-/VLA-1 -) ; more than 50% express theTCRa//3 while only a small fraction
are TCRy/b' . Epidermal TCs were propagated in vitro from EC suspensions
(using Con A, IL-1, IL-2), resulting in the establishment of long-term suspension
cultures which by FRCS and immunoprecipitation were determined to containTCR
od3- and TCR-y/b-bearing cells . Furthermore, we demonstrated that epidermal TCs1008
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FIGURE' 6 .
￿
Electron micrograph of sole skin illustrating the close association (small arrows) be-
tween aLC containing Birbeck granules (small arrowhead) and an immunolabeled CD5` epidermal
TC located just above the dermis (D). The peroxidase-reaction product (large arrowheads) is re-
stricted to the TC plasmalemma, which appears to be "fusing" with the LC membrane . KC,
keratinocyte . x 18,400 .
FIGURE 7 . Immunoprecipi-
tation andSDS-PAGE analysis
ofthe C133-associatedmolecules
expressed on two different epi-
dermal TC cultures . The cells
used in a and bwere grown in
culture (as described in Mate-
rialsandMethods) for 14 dbe-
fore 1251 labeling . Anti-CD3
and antiTCR immunopreci-
pitates were made from digi-
tonin and NP-40 lysates, respec-
tively, then analyzed under
reducingandnonreducingcon-
ditions . Some representative
lysates (NP-40, lanes 1-4 ; di-
gitonin, lane 5) under reducing
conditions are shown here.
Normal rabbit serum (lane 1);
antiTCRa(lane 2); antiTCR-
0(lane 3) ; antiTCRy (lane 4);
anti-CD3S (lane 5) . The posi-
tions of the molecular mass
markers (kD) are indicated on
the left .FOSTER ET AL.
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were significantly more abundant in the sole than in the trunk and limbs (i.e., 40
vs. 7 CD3' cells/linear centimeter of epidermis), thus providing the first evidence
for significant regional variability within this cutaneous population. Epidermal TCs
were often in close association with LCs, and in addition, TC/LC ratios were
significantly different in volar vs. nonvolar regions (i.e., CD3'/CD2' TCs repre-
sent 63% of the number of CDla' cells in plantar epidermis as compared with 6170
in the trunk and limbs).
Preliminary analyses indicate that palm skin also harbors a larger number of
epidermal TCs, as compared with the trunk and limbs (Foster, C. A., unpublished
observations). Experiments are in progress to determine which factors are respon-
sible for these observed regional differences, but at the present time we propose the
following speculations: (a) epidermal TC density is proportional to the concentra-
tion and type (eccrine vs. apocrine) of sweat glands within a body area. The en-
hanced epidermotropism ofTCs to plantarskin, which contains the highest number
(620/cm2) of eccrine sweat glands (28), may be related to chemoattractants possibly
associated with the eccrine ultrafiltrateand/or acrosyringialepithelium (e.g., microbial
products gaining access into the skin via adnexal openings, IL-1 [29] and other
cytokines, and soluble antigens); (b) TC epidermotropism may be enhanced due
to altered MHC classII expression by acrosyringial epithelium, the only KC in normal
skin that are HLA-DR' (30); (c) adhesion molecules (reviewed in references 31, 32)
expressed by endothelial cells, leukocytes and KC may differ qualitatively and/or
quantitatively in certain cutaneous sites; (d) the extensive vascular network around
sweat glands, coupled with the influence of gravity, may favorincreased diapedesis
of TCs from subepidermal capillaries and venules to the plantar epidermis. One
or more of these conditions could not only selectively attract epidermal TCs but
could also discourage the residency of LCs, which are reduced significantly in volar
skin (33-35).
We have demonstrated that there are major differences between human and mu-
rine epidermal TCs. While the latter cells are uniformly dendritic in shape and ex-
press a distinctive TCR--y/b phenotype, human epidermal CD3' cells are variable
in shape (spherical to polygonal, or only slightly dendritic), and the vast majority
bear TCR-a/0 rather than y/b heterodimers. In contrast to a previous report that
>75% of epidermal TCs were HLA-DR'/CD25' and that subepidermal accumu-
lations of TCs were never observed in normal skin (6), the present study demon-
strated that only 6-30% expressed markers of activation and that TCs were often
more abundant just beneath the basement membrane than throughout the deeper
dermis. Furthermore, contrary to the situation in peripheral blood where there are
almost twiceas many helper/inducer as suppressor/cytotoxic TCs (21) and only about
56% and 40% are CD45RO', respectively (calculated from references 36 and 37),
we observed an approximate 2:3 ratio of epidermal CD4' to CD8' TCs, both of
which were predominantly 2H4-/UCHL1'. Thus, based on the present study it
seems reasonable to speculate that a subpopulation of TCs, previously sensitized
to cutaneous antigen(s), specifically "home" to the skin and remain there in a resting
state of readiness until coming into contact with the appropriate antigen. This sce-
nario could imply that, at leastin the adult, the TCR repertoire ofhuman epidermal
TCs is restricted and preselected, rather than promiscuous. Since we have demon-
strated that epidermal TCs can be propagated and maintained in long-termculture,1010
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it should be possible to address these issues using molecular biology techniques in
conjunction with functional assays.
It is unclear why sometimes only a portion of the CD2+/CD3+/CD5' (TCR//b-)
epidermalcells in frozen sections were labeledby antiTCRa//3 and anti-CD7 mobs
(Table II). One explanation could be limited sensitivity of the immunolabeling tech-
nique, but this seems unlikely since the peroxidase reaction product was appropri-
ately intense on those cells that were (3F1 +, BMA031', or Leu 9+. With respect to
Leu 9 staining, perhapsCD7 is downregulated/modulated (38) within the epidermal
microenvironment or expressedon only aphenotypically unique, but as yet uniden-
tified subset of TCs; interestingly, our epidermal TC cultures also were not uni-
formly CD7+. Regarding TCR-a/(3, some CD3' epidermal TCs may only express
cytoplasmic CD3 but no surface TCRassociated chains. Finally, it is conceivable
that the CD3+/TCR-u/0_/TCR-y/S- cells express a third type of TCR that could
not be recognized by our reagents.
At the present time it is technically difficult to clarify the exact physiological role
of epidermal TCs, since phenotypic studies have their limitations with regard to
biological implications. Ourultrastructural data certainlyindicate that LCs canoccur
in close association with epidermal TCs under normal physiological conditions,
forming zones of contact that are similar to those observed in contact dermatitis
and mycosis fungoides (39, 40). Thus, the necessary ingredients for an immune re-
sponse presumably would be available within the epidermis without the necessity
for TC recruitment from a regional lymph node and without eliciting signs of an
overtimmunologicalreaction. According to ourpresentstate ofknowledge, this sce-
nario would be most compatible with epidermal CD4' TCs. However, it is less ob-
vious why CD8' TCs seem to preferentially migrate into the epidermis, usually as
the predominant subset. Do they have tissue-specific homing receptors that are in-
dependent of antigen or dependent on prior sensitization? With regard to possible
effector functions, are these CDh' cells MHC-restricted or more similar to natural
killer cells; do they secrete a distinct subset oflymphokines? These and other ques-
tions remain unanswered until epidermal TC cultures are analyzed for their TCR
repertoire andfunctional activity relative to different cutaneous targets(e.g., allogeneic,
autologous, environmental, microbial, and tumor-specific antigens). Such studies
should enable us to clarify the postulated role of epidermal TCs in cutaneous im-
munesurwillance, as defined by the SALT concept(skin-associated lymphoid tissues
41, 42).
Summary
The epidermis of clinically normal-appearing human skin harbors a phenotypi-
cally heterogeneous population of T lymphocytes (TCs), the majority of which are
Cr)2*/CD3*/CD5+ "memory" cells, but in an unactivated state, and express the
TCRa/(3 In contrast to murine skin, only a very minor subpopulation of CDR*
cells in the human epidermis bears the TCR.-y/&, Epidermal Ws primarily arc dis=
tributed along the rete ridges in the basal keratinocyte layer and are often in close
apposition to Langerhans cells (Ms), These TCs were propagated from epidermal
cell suspensions after stimulation with TC activating agents (Con A, rIL-1, rIL-2),
then evaluated forphenotypic features and TCR diversity. Similar to the in situ situ-FOSTER ET AL.
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ation, most were CD4 -/CD8+/TCR-a/g + . In addition, two cultures contained
TCR,y/S' cells; one of these was determined to be an adherent CD4-/CD8 + popu-
lation.
Epidermal TCs were significantly (p <0.0001) more abundant in the sole than in
the other body regions examined (i.e., 40 vs. 7 CD3 + cells/linear centimeter of
epidermis) and seemed to have a particular affinity for the acrosyringial epithelium
of eccrine sweat ducts. Moreover, the sole usually contained a greater number of
CD8+ relative to CD4+ TCs, whereas the epidermal CD4/CD8 ratio in the trunk
and extremities was quite variable, although the trend also was towards a slightly
larger percentage of CD8+ cells. Collectively, our data suggest that the volar
epidermis has a unique microenvironment which is responsible for both the higher
density of TCs, preferentially CD8+ , and lower number of LCs. This study has not
only provided evidence for significant regional variability in the human epidermal
TC population of normal skin, but also strengthens the concept for skin-associated
lymphoid tissues (SALT), whereby memory TCs recirculate back to the epidermis
and interact with resident antigen-presenting cells (i.e., LC).
We are grateful to Dr. Michael Kundi for statistical consultation; to Ms. Irene Assmann,
Ms. Uschi Hornick, Ms. Isabella Mosberger, and Ms. Inge Wadlig for their technical exper-
tise; to Mr. Wilhelm Prosche and Dr. Robert Strohal for advice with computer program-
ming; to Mr. Heinz Gaudek for the photographic work; and to Ms. Sylvia Hermanek and
Ms. Renate Kopp for secretarial assistance.
Receivedfor publication 16 October 1989 and in revisedform 20 December 1989.
References
1 . Stingl, G., C. Hauser, E. Tschachler, V. Groh, and K. Wolff. 1989. Immune functions
of epidermal cells. In Immune Mechanisms in Cutaneous Disease. D. A. Norris, editor.
Marcel Dekker, Inc., New York. 3-72.
2. Andrew, W., and N. V. Andrew. 1949. Lymphocytes in the normal epidermis of the rat
and of man. Anat. Rec. 104:217.
3. Cooper, K. D., S. M. Breathnach, S. W. Caughman, A . G. Palini, M. J. Waxdal, and
S. I. Katz. 1985. Fluorescence microscopic and flow cytometric analysis ofbone marrow-
derived cells in human epidermis: a search for the human analogue of the murine den-
dritic Thy-1' epidermal cell. J. Invest. Dermatol. 85:546.
4. Cohen, R. L., J. M. Crawford, and D. A. Chambers. 1986. Thy-1' epidermal cells are
not demonstrable in rat and human skin. J. Invest. Dermatol. 87:30.
5 . Smolle, J., R. Ehall, and H. Kerl. 1985. Inflammatory cell types in normal human
epidermis. An immunohistochemical and morphometric study. Acta. Dermato-Venereol.
65:479.
6. Bos, J. D., I. Zonneveld, P K. Das, S. R. Krieg, C. M . van der Loos, and M. L. Kapsen-
berg. 1987. The skin immune system (SIS): distribution and immunophenotypeoflym-
phocyte subpopulations in normal human skin. ,J. Invest. Dermatol. 88:569.
7 . Rowden, G., D. Davis, D. Luckett, and L. Poulter. 1988. Identification of CD4', 2H4'
(T8-y+) suppressor-inducer cells in normal human epidermis and superficial dermis. Br.
J Dermatol. 119:147.
8. Foster, C. A., and G. Sting]. 1990. T cell receptor .y/6-bearing cells in the epidermis.
Curr. Probl. Dermatol 19:9.
9 . Groh, V., S. Porcelli, M. Fabbi, L. L. Lanier, L. J. Picker, T. Anderson, R. A. Warnke,101 2
￿
T CELLS IN THE NORMAL HUMAN EPIDERMIS
A. K. Bhan, J. L. Strominger, and M. B. Brenner. 1989. Human lymphocytes bearing
T cell receptor y/S are phenotypically diverse and evenly distributed throughoutthe lym-
phoid system. J Exp. Med. 169:1277.
10 . Juhlin, L., W. B. Shelley. 1977. New staining techniques for the Langerhans cell. Acta.
Dermato-Venereol. 57:289.
11 . Kitano, Y., N. Okada. 1983. Separation ofthe epidermal sheet by dispase. Br.J. Dermatol.
108:555.
12 . McLean, I. W., and P. K. Nakane. 1974. Periodate lysine-paraformaldehyde fixative.
A new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22 :1077.
13 . Karnovsky, M. H. 1965. A formaldehyde-glutaraldehyde fixative of high osmolarity for
use in electron microscopy. .): Cell Biol. 27:137A.
14 . Foster, C. A., K. A. Holbrook, and A. G. Farr. 1986. Ontogeny of Langerhans cells in
human embryonic and fetal skin: expression of HLA-DR and OKT6 determinants.J.
Invest. Dermatol. 86:240.
15 . Kruskal, W. H., and W. A. Wallis. 1952. Use of ranks in one-criterion variance analysis.
J. Am. Statist. Assoc. 47:583.
16 . Mann, H . B., and D. R. Whitney. 1947 . On a test of whether one of two random vari-
ables is stochastically larger than the other. Ann. Math. Statist. 18:50.
17 . Koning, F., W. L. Maloy, D. Cohen, and J. E. Coligan. 1987 . Independent association
of T cell receptor (3 and y chains with CD3 in the same cell.J. Exp. Med. 166:595.
18 . Koning, F., A. M. Lew, W. L. Maloy, R. Valas, and J. E. Coligan. 1988. The biosyn-
thesis and assembly of T cell receptor a- and /3-chains with the CD3 complex. J. Im-
munol. 140:3126.
19 . Groh, V., H. Yokozeki, W. M. Yokoyama, F. Koning, C. A. Foster, and G. Stingl. 1988.
The human epidermis harbors CDl'/CD3`/TCR gamma'/HLA-DR' dendritic cells.
J. Invest. Dermatol. 90:241.
20 . Warnke, R. A., K. C. Gatter, B. Falini, P Hildreth, R. E. Woolston, K. Pulford, J. L.
Cordell, B. Cohen, C. de Wolf-Peeters, and D. Y. Mason. 1983. Diagnosis of human
lymphoma with monoclonal antileukocyte antibodies. N. Engl. J. Med. 309:1275.
21 . Ashmore, L. M., G. M. Shopp, and B. S. Edwards. 1989. Lymphocyte subset analysis
by flow cytometry. Comparison of three different techniques and effects of blood storage.
J. Immunol. Methods. 118:209.
22 . Akbar, A. N., L. Terry, A. Timms, P C. L. Beverley, and G. Janossy. 1988. Loss ofCD45R
and gain of UCHLI reactivity is a feature of primed T cells. J. Immunol. 140:2171.
23 . Merkenschlager, M ., L. Terry, R. Edwards, and P. C. L. Beverley. 1988. Limiting dilu-
tion analysis of proliferative responses in human lymphocyte populations defined by the
monoclonal antibody UCHLI: implications for differential CD45 expression in T cell
memory formation. Eur. f Immunol. 18:1653.
24. Merkenschlager, M ., and P. C. L. Beverley. 1990 . Evidence for differential expression
of CD45 isoforms by precursors for memory dependent and independent cytotoxic re-
sponses: human CD8 memory CTLp selectively express CD45RO (UCHLI). Int. Im-
munol. In press.
25 . Sanders, M. E., M. W. Makgoba, S. O. Sharrow, D. Stephany, T. A. Springer, H. A.
Young, and S. Shaw. 1988. Human memory T lymphocytes express increased levels of
three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules
(UCHLI, CDw29, and Pgp-1) and have enhanced IFN-y production.) Immunol. 140:1401 .
26. Hogg, N. 1989. The leukocyte integrins. Immunol. Today. 10:111.
27 . Brenner, M. B., J . L. Strominger, and M. S. Krangel. 1988. The yS T cell receptor.
Adv. Immunol. 43:133.
28. Sato, K. 1987. Biology of eccrine sweat glands. In Dermatology in General Medicine.FOSTER ET AL.
￿
1013
3rd Edition. T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, 1. M. Freedberg, andK. F. Austen,
editors. McGraw-Hill Book Co., New York. 195-209.
29. Didierjean, L., A. Shaw, J. M. Dayer, and J. H. Saurat. 1988. Immunoreactive IL-1
alpha and beta in human sweat and heel callus.f. Invest. Dermatol. 90:554.
30. Murphy, G. F, R. S. Shepard, T J. Harrist, B. R. Bronstein, and A. K. Bhan. 1983 .
Ultrastructural documentationof HLA-DR antigen reactivity in normal humanacrosyrin-
gial epithelium. J Invest. Dermatol. 81:181.
31 . Hemler, M. E. 1989. Adhesive proteinreceptorson hematopoietic cells. Immunol. Today.
9:109.
32 . Stoolman, L. M. 1989. Adhesion moleculescontrolling lymphocyte migration. Cell. 56:907.
33 . Berman, B., V . L. Chen, D. S. France, W. 1. Dotz, and G. Petroni. 1983. Anatomical
mapping of epidermal Langerhans cell densities in adults. Br. f. Dermatol. 109:553.
34. Thomas,J. A., M. Biggerstaff, J. P. Sloane, and D. F Easton. 1984. Immunological and
histochemical analysis of regional variations of epidermal Langerhans cells in normal
human skin. Histochem. J. 16:507 .
35 . Ashworth,J., M. L. Turbitt, and R. Mackie. 1986. Thedistribution and quantification
of the Langerhans cell in normal human epidermis. Clin. Exp. Dermatol. 11:153.
36. Morimoto, C., N. L. Letvin, A. W. Boyd, M. Hagan, H. M. Brown, M. M. Kornacki,
and S. F. Schlossman. 1985. The isolation andcharacterization of the human helper in-
ducer T cell subset. J. Immunol. 134:3762.
37 . Smith, S. H., M. H. Brown, D. Rowe, R. E. Callard, and P C. L. Beverley. 1986. Func-
tional subsets of human helper-inducer cells defined by a new monoclonal antibody,
UCHLI. Immunology. 58:63.
38. Lazarovits, A. I., R. B. Colvin, D. Camerini,J. Karsh, andJ. T. Kurnick. 1987 . Modu-
lation of CD7 is associated with T -lymphocyte function. In Leukocyte Typing 111. A. J.
McMichael, et al., editors. Oxford University Press, New York. 219-223.
39. Silberberg, I. 1973. Apposition of mononuclear cells to Langerhans cells in contact al-
lergic reactions. Acta. Dermato-Venereol. 53 :1.
40. Concha, M., C. D. Figueroa, and I. Caorsi. 1988. Ultrastructural characteristics of the
contact zones between Langerhans cells and lymphocytes. J. Pathol. 156:29.
41 . Streilein, J. W 1978. Lymphocyte traffic, Tcell malignancies and the skin] Invest. Der-
matol. 71:167.
42 . Streilein, J. W 1983 . Skin-associated lymphoid tissues (SALT): origins and functions.
f. Invest. Dermatol. 80:12s.